{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.05, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [1131, 103, 1429, 117, 1426, 170, 1128, 155], "text": "Baror", "words": [{"boundingBox": [1145, 104, 1302, 113, 1303, 161, 1147, 157], "text": "Baror", "confidence": "Low"}]}, {"boundingBox": [1521, 92, 1571, 87, 1575, 143, 1524, 149], "text": "8", "words": [{"boundingBox": [1532, 90, 1566, 86, 1572, 143, 1538, 147], "text": "8"}]}, {"boundingBox": [801, 182, 885, 182, 884, 220, 801, 220], "text": "draft", "words": [{"boundingBox": [811, 182, 884, 182, 884, 220, 811, 220], "text": "draft"}]}, {"boundingBox": [1262, 168, 1598, 158, 1600, 196, 1264, 206], "text": "::: 12- 4- 13 pv", "words": [{"boundingBox": [1265, 169, 1345, 167, 1345, 204, 1266, 206], "text": ":::", "confidence": "Low"}, {"boundingBox": [1373, 166, 1436, 164, 1436, 202, 1374, 204], "text": "12-"}, {"boundingBox": [1443, 164, 1491, 163, 1492, 200, 1444, 201], "text": "4-", "confidence": "Low"}, {"boundingBox": [1498, 162, 1539, 161, 1540, 198, 1499, 200], "text": "13"}, {"boundingBox": [1546, 161, 1599, 159, 1600, 196, 1547, 198], "text": "pv", "confidence": "Low"}]}, {"boundingBox": [283, 269, 813, 271, 812, 306, 282, 305], "text": "FDA Conference Call: August 13, 2002", "words": [{"boundingBox": [287, 271, 349, 272, 349, 304, 287, 303], "text": "FDA"}, {"boundingBox": [359, 272, 512, 272, 512, 306, 359, 304], "text": "Conference"}, {"boundingBox": [519, 272, 593, 272, 592, 306, 518, 306], "text": "Call:"}, {"boundingBox": [599, 272, 697, 271, 695, 307, 599, 306], "text": "August"}, {"boundingBox": [703, 271, 742, 271, 741, 307, 702, 307], "text": "13,"}, {"boundingBox": [748, 271, 812, 271, 811, 307, 747, 307], "text": "2002"}]}, {"boundingBox": [285, 342, 499, 344, 498, 373, 284, 372], "text": "FDA Personnel;", "words": [{"boundingBox": [289, 343, 347, 344, 348, 373, 290, 371], "text": "FDA"}, {"boundingBox": [358, 345, 498, 344, 498, 372, 359, 373], "text": "Personnel;", "confidence": "Low"}]}, {"boundingBox": [283, 409, 865, 413, 864, 447, 282, 444], "text": "Jeri El-Hage, Ph.D., Toxicology Team Leader", "words": [{"boundingBox": [285, 410, 332, 411, 332, 445, 286, 444], "text": "Jeri"}, {"boundingBox": [338, 411, 449, 413, 449, 446, 339, 445], "text": "El-Hage,"}, {"boundingBox": [455, 413, 539, 413, 540, 446, 456, 446], "text": "Ph.D.,"}, {"boundingBox": [546, 413, 689, 414, 690, 446, 546, 446], "text": "Toxicology"}, {"boundingBox": [696, 414, 762, 414, 763, 446, 697, 446], "text": "Team"}, {"boundingBox": [771, 414, 864, 413, 865, 446, 772, 446], "text": "Leader"}]}, {"boundingBox": [284, 445, 658, 448, 657, 481, 283, 477], "text": "Jena Weber, Project Manager", "words": [{"boundingBox": [286, 445, 345, 447, 345, 478, 286, 477], "text": "Jena"}, {"boundingBox": [352, 447, 442, 449, 441, 479, 351, 478], "text": "Weber,"}, {"boundingBox": [448, 449, 536, 450, 535, 480, 447, 479], "text": "Project"}, {"boundingBox": [543, 450, 658, 449, 655, 480, 541, 480], "text": "Manager"}]}, {"boundingBox": [285, 539, 519, 541, 518, 573, 284, 571], "text": "TPNA Personnel:", "words": [{"boundingBox": [289, 542, 368, 543, 368, 572, 290, 570], "text": "TPNA"}, {"boundingBox": [378, 543, 518, 541, 517, 573, 379, 572], "text": "Personnel:"}]}, {"boundingBox": [285, 610, 1063, 612, 1062, 644, 284, 642], "text": "David Baron, Ph.D., Director, Nonclinical Safety and Efficacy", "words": [{"boundingBox": [285, 612, 364, 612, 364, 642, 285, 642], "text": "David"}, {"boundingBox": [370, 612, 452, 612, 453, 643, 370, 642], "text": "Baron,"}, {"boundingBox": [458, 612, 539, 612, 540, 643, 459, 643], "text": "Ph.D.,"}, {"boundingBox": [545, 612, 658, 612, 658, 644, 545, 643], "text": "Director,"}, {"boundingBox": [663, 612, 811, 612, 812, 644, 664, 644], "text": "Nonclinical"}, {"boundingBox": [817, 612, 896, 612, 896, 644, 818, 644], "text": "Safety"}, {"boundingBox": [902, 612, 948, 612, 948, 644, 902, 644], "text": "and"}, {"boundingBox": [953, 612, 1062, 612, 1062, 645, 954, 644], "text": "Efficacy"}]}, {"boundingBox": [287, 643, 831, 646, 830, 680, 286, 677], "text": "Janet Haskins, Manager, Regulatory Affairs", "words": [{"boundingBox": [287, 645, 352, 646, 352, 677, 287, 676], "text": "Janet"}, {"boundingBox": [358, 646, 466, 647, 465, 678, 358, 677], "text": "Haskins,"}, {"boundingBox": [472, 647, 591, 648, 591, 679, 471, 678], "text": "Manager,"}, {"boundingBox": [598, 648, 742, 647, 740, 680, 597, 679], "text": "Regulatory"}, {"boundingBox": [748, 647, 831, 646, 829, 679, 746, 680], "text": "Affairs"}]}, {"boundingBox": [282, 678, 729, 680, 728, 714, 281, 712], "text": "Pat Frank, Ph.D., TPNA Consultant", "words": [{"boundingBox": [285, 680, 326, 680, 325, 713, 284, 713], "text": "Pat"}, {"boundingBox": [332, 680, 414, 680, 413, 713, 332, 713], "text": "Frank,"}, {"boundingBox": [420, 680, 504, 680, 503, 713, 420, 713], "text": "Ph.D.,"}, {"boundingBox": [511, 680, 590, 680, 589, 714, 510, 713], "text": "TPNA"}, {"boundingBox": [599, 680, 730, 682, 728, 715, 598, 714], "text": "Consultant"}]}, {"boundingBox": [284, 792, 1401, 789, 1402, 826, 285, 828], "text": "This teleconference was held as a follow-up to a discussion between TPNA and the", "words": [{"boundingBox": [289, 794, 347, 794, 348, 827, 291, 826], "text": "This"}, {"boundingBox": [353, 794, 540, 795, 541, 828, 354, 827], "text": "teleconference"}, {"boundingBox": [548, 795, 604, 795, 605, 828, 550, 828], "text": "was"}, {"boundingBox": [610, 795, 670, 795, 671, 828, 611, 828], "text": "held"}, {"boundingBox": [678, 795, 710, 795, 711, 828, 679, 828], "text": "as"}, {"boundingBox": [716, 795, 738, 795, 739, 828, 717, 828], "text": "a"}, {"boundingBox": [746, 795, 871, 795, 873, 828, 747, 828], "text": "follow-up", "confidence": "Low"}, {"boundingBox": [880, 795, 910, 795, 911, 828, 881, 828], "text": "to"}, {"boundingBox": [918, 795, 939, 795, 940, 828, 919, 828], "text": "a"}, {"boundingBox": [952, 795, 1080, 794, 1081, 827, 953, 828], "text": "discussion"}, {"boundingBox": [1086, 794, 1196, 793, 1197, 827, 1087, 827], "text": "between"}, {"boundingBox": [1209, 792, 1286, 792, 1287, 826, 1210, 826], "text": "TPNA"}, {"boundingBox": [1300, 791, 1351, 791, 1352, 825, 1301, 826], "text": "and"}, {"boundingBox": [1358, 791, 1400, 790, 1401, 825, 1359, 825], "text": "the"}]}, {"boundingBox": [286, 844, 1401, 842, 1402, 877, 287, 880], "text": "Agency on July 31, 2002. The purpose of this this conference call was so that Dr. El-", "words": [{"boundingBox": [287, 845, 386, 845, 386, 880, 288, 880], "text": "Agency"}, {"boundingBox": [392, 845, 427, 846, 427, 880, 393, 880], "text": "on"}, {"boundingBox": [434, 846, 491, 846, 491, 880, 434, 880], "text": "July"}, {"boundingBox": [497, 846, 538, 846, 539, 880, 498, 880], "text": "31,", "confidence": "Low"}, {"boundingBox": [545, 846, 630, 846, 630, 880, 546, 880], "text": "2002.", "confidence": "Low"}, {"boundingBox": [641, 846, 689, 846, 689, 879, 641, 880], "text": "The", "confidence": "Low"}, {"boundingBox": [696, 846, 799, 846, 799, 879, 696, 879], "text": "purpose"}, {"boundingBox": [805, 845, 833, 845, 833, 879, 806, 879], "text": "of"}, {"boundingBox": [840, 845, 888, 845, 888, 879, 840, 879], "text": "this"}, {"boundingBox": [894, 845, 945, 845, 945, 879, 895, 879], "text": "this", "confidence": "Low"}, {"boundingBox": [951, 845, 1091, 844, 1091, 878, 952, 879], "text": "conference"}, {"boundingBox": [1097, 844, 1148, 844, 1148, 878, 1097, 878], "text": "call"}, {"boundingBox": [1154, 844, 1205, 844, 1205, 877, 1154, 878], "text": "was"}, {"boundingBox": [1211, 844, 1243, 844, 1243, 877, 1211, 877], "text": "so"}, {"boundingBox": [1250, 844, 1300, 843, 1300, 877, 1250, 877], "text": "that"}, {"boundingBox": [1307, 843, 1353, 843, 1353, 877, 1307, 877], "text": "Dr."}, {"boundingBox": [1360, 843, 1401, 842, 1401, 876, 1360, 877], "text": "El-"}]}, {"boundingBox": [286, 895, 1399, 895, 1398, 931, 285, 930], "text": "Hage could expand upon the nonclinical data related to dual PPAR agonist that was", "words": [{"boundingBox": [286, 895, 356, 896, 357, 931, 286, 930], "text": "Hage"}, {"boundingBox": [363, 896, 439, 896, 439, 931, 364, 931], "text": "could"}, {"boundingBox": [445, 896, 541, 896, 542, 931, 446, 931], "text": "expand"}, {"boundingBox": [548, 896, 617, 896, 617, 931, 548, 931], "text": "upon"}, {"boundingBox": [623, 896, 669, 896, 669, 932, 624, 932], "text": "the"}, {"boundingBox": [676, 896, 824, 896, 824, 932, 676, 932], "text": "nonclinical"}, {"boundingBox": [831, 896, 884, 896, 884, 932, 831, 932], "text": "data"}, {"boundingBox": [891, 896, 982, 896, 982, 932, 890, 932], "text": "related"}, {"boundingBox": [989, 896, 1023, 897, 1023, 932, 989, 932], "text": "to", "confidence": "Low"}, {"boundingBox": [1032, 897, 1085, 897, 1084, 932, 1032, 932], "text": "dual"}, {"boundingBox": [1091, 897, 1174, 897, 1173, 932, 1091, 932], "text": "PPAR"}, {"boundingBox": [1185, 897, 1279, 897, 1278, 931, 1185, 932], "text": "agonist"}, {"boundingBox": [1285, 897, 1343, 896, 1342, 931, 1285, 931], "text": "that"}, {"boundingBox": [1349, 896, 1397, 896, 1397, 931, 1349, 931], "text": "was"}]}, {"boundingBox": [288, 948, 1189, 947, 1190, 981, 289, 982], "text": "discussed shared-with TPNA onduring-the July 31, 2002.-conference call.", "words": [{"boundingBox": [291, 948, 406, 948, 406, 983, 291, 983], "text": "discussed"}, {"boundingBox": [412, 948, 558, 948, 559, 983, 413, 983], "text": "shared-with"}, {"boundingBox": [565, 948, 646, 948, 646, 983, 565, 983], "text": "TPNA"}, {"boundingBox": [653, 948, 810, 948, 810, 982, 653, 983], "text": "onduring-the"}, {"boundingBox": [816, 948, 868, 948, 868, 982, 817, 982], "text": "July"}, {"boundingBox": [875, 948, 913, 949, 913, 982, 875, 982], "text": "31,"}, {"boundingBox": [920, 949, 1133, 949, 1133, 981, 920, 982], "text": "2002.-conference", "confidence": "Low"}, {"boundingBox": [1140, 949, 1189, 949, 1190, 981, 1140, 981], "text": "call.", "confidence": "Low"}]}, {"boundingBox": [283, 1053, 1400, 1055, 1399, 1088, 282, 1086], "text": "Dr. El-Hage informed TPNA that nonclinical data observed in several standard 2-year rat", "words": [{"boundingBox": [285, 1055, 328, 1055, 329, 1085, 286, 1085], "text": "Dr."}, {"boundingBox": [334, 1055, 437, 1056, 439, 1085, 335, 1085], "text": "El-Hage"}, {"boundingBox": [443, 1056, 563, 1057, 564, 1086, 445, 1085], "text": "informed"}, {"boundingBox": [568, 1057, 645, 1058, 646, 1086, 570, 1086], "text": "TPNA", "confidence": "Low"}, {"boundingBox": [655, 1058, 703, 1058, 705, 1087, 656, 1086], "text": "that"}, {"boundingBox": [709, 1058, 852, 1058, 854, 1087, 711, 1087], "text": "nonclinical"}, {"boundingBox": [858, 1058, 909, 1058, 911, 1087, 860, 1087], "text": "data"}, {"boundingBox": [915, 1058, 1026, 1058, 1028, 1088, 916, 1087], "text": "observed"}, {"boundingBox": [1032, 1058, 1062, 1058, 1063, 1088, 1034, 1088], "text": "in"}, {"boundingBox": [1068, 1058, 1158, 1057, 1159, 1088, 1069, 1088], "text": "several"}, {"boundingBox": [1163, 1057, 1269, 1056, 1270, 1088, 1165, 1088], "text": "standard"}, {"boundingBox": [1275, 1056, 1355, 1055, 1357, 1088, 1276, 1088], "text": "2-year"}, {"boundingBox": [1361, 1055, 1398, 1055, 1400, 1088, 1362, 1088], "text": "rat"}]}, {"boundingBox": [278, 1110, 1400, 1107, 1401, 1140, 279, 1142], "text": "and mouse bioassay studies with several other dual PPAR agonists, similar-to", "words": [{"boundingBox": [284, 1112, 337, 1112, 338, 1139, 286, 1139], "text": "and"}, {"boundingBox": [349, 1112, 435, 1111, 436, 1140, 351, 1139], "text": "mouse"}, {"boundingBox": [452, 1111, 562, 1111, 564, 1141, 454, 1140], "text": "bioassay"}, {"boundingBox": [582, 1111, 672, 1111, 674, 1141, 583, 1141], "text": "studies"}, {"boundingBox": [688, 1111, 746, 1110, 747, 1141, 689, 1141], "text": "with"}, {"boundingBox": [765, 1110, 861, 1110, 862, 1141, 766, 1141], "text": "several", "confidence": "Low"}, {"boundingBox": [875, 1110, 945, 1110, 946, 1141, 876, 1141], "text": "other"}, {"boundingBox": [963, 1110, 1020, 1109, 1021, 1141, 964, 1141], "text": "dual"}, {"boundingBox": [1033, 1109, 1108, 1109, 1109, 1140, 1034, 1141], "text": "PPAR"}, {"boundingBox": [1134, 1109, 1251, 1109, 1252, 1139, 1135, 1140], "text": "agonists,"}, {"boundingBox": [1263, 1109, 1398, 1108, 1399, 1138, 1264, 1139], "text": "similar-to", "confidence": "Low"}]}, {"boundingBox": [284, 1160, 1404, 1157, 1405, 1192, 285, 1195], "text": "pioglitazone, were shown to cause transitional cell tumors in the bladder and kidneys of", "words": [{"boundingBox": [285, 1163, 450, 1163, 451, 1193, 286, 1192], "text": "pioglitazone,", "confidence": "Low"}, {"boundingBox": [456, 1163, 518, 1163, 518, 1193, 456, 1193], "text": "were"}, {"boundingBox": [524, 1163, 609, 1163, 610, 1194, 524, 1193], "text": "shown"}, {"boundingBox": [615, 1163, 644, 1163, 644, 1194, 615, 1194], "text": "to"}, {"boundingBox": [652, 1163, 721, 1163, 722, 1194, 652, 1194], "text": "cause"}, {"boundingBox": [727, 1163, 870, 1162, 871, 1194, 728, 1194], "text": "transitional"}, {"boundingBox": [876, 1162, 923, 1162, 924, 1194, 877, 1194], "text": "cell"}, {"boundingBox": [928, 1162, 1019, 1161, 1021, 1194, 930, 1194], "text": "tumors"}, {"boundingBox": [1025, 1161, 1052, 1161, 1054, 1194, 1027, 1194], "text": "in"}, {"boundingBox": [1058, 1161, 1101, 1161, 1102, 1193, 1060, 1194], "text": "the"}, {"boundingBox": [1107, 1161, 1203, 1160, 1205, 1193, 1108, 1193], "text": "bladder"}, {"boundingBox": [1209, 1160, 1256, 1159, 1257, 1193, 1211, 1193], "text": "and"}, {"boundingBox": [1262, 1159, 1364, 1158, 1366, 1192, 1263, 1193], "text": "kidneys"}, {"boundingBox": [1370, 1158, 1403, 1158, 1405, 1192, 1372, 1192], "text": "of"}]}, {"boundingBox": [280, 1212, 1402, 1214, 1401, 1247, 279, 1245], "text": "male and female rats and male mice Therefore, the Division is considering the relevance", "words": [{"boundingBox": [284, 1213, 346, 1213, 348, 1245, 285, 1244], "text": "male"}, {"boundingBox": [353, 1213, 399, 1213, 400, 1245, 354, 1245], "text": "and"}, {"boundingBox": [405, 1213, 488, 1213, 489, 1245, 406, 1245], "text": "female"}, {"boundingBox": [494, 1213, 543, 1213, 544, 1246, 496, 1245], "text": "rats"}, {"boundingBox": [549, 1213, 596, 1213, 597, 1246, 550, 1246], "text": "and"}, {"boundingBox": [602, 1213, 663, 1213, 664, 1246, 603, 1246], "text": "male"}, {"boundingBox": [669, 1213, 737, 1214, 739, 1246, 670, 1246], "text": "mice"}, {"boundingBox": [758, 1214, 883, 1214, 884, 1247, 759, 1247], "text": "Therefore,"}, {"boundingBox": [889, 1214, 930, 1214, 931, 1247, 890, 1247], "text": "the"}, {"boundingBox": [936, 1214, 1043, 1214, 1044, 1247, 937, 1247], "text": "Division"}, {"boundingBox": [1049, 1214, 1072, 1214, 1073, 1247, 1050, 1247], "text": "is"}, {"boundingBox": [1078, 1214, 1224, 1215, 1225, 1247, 1079, 1247], "text": "considering"}, {"boundingBox": [1230, 1215, 1268, 1215, 1269, 1247, 1231, 1247], "text": "the"}, {"boundingBox": [1274, 1215, 1400, 1215, 1401, 1247, 1275, 1247], "text": "relevance"}]}, {"boundingBox": [284, 1265, 1396, 1263, 1397, 1298, 284, 1299], "text": "of these findings to becoming concerned with-the potentially long term tumorigenic", "words": [{"boundingBox": [284, 1265, 316, 1265, 317, 1300, 286, 1300], "text": "of"}, {"boundingBox": [323, 1265, 395, 1266, 397, 1300, 324, 1300], "text": "these"}, {"boundingBox": [402, 1266, 509, 1266, 510, 1300, 403, 1300], "text": "findings"}, {"boundingBox": [516, 1266, 550, 1266, 551, 1300, 517, 1300], "text": "to"}, {"boundingBox": [556, 1266, 688, 1267, 689, 1300, 557, 1300], "text": "becoming"}, {"boundingBox": [695, 1267, 829, 1267, 829, 1299, 696, 1300], "text": "concerned"}, {"boundingBox": [835, 1267, 951, 1266, 951, 1299, 836, 1299], "text": "with-the", "confidence": "Low"}, {"boundingBox": [958, 1266, 1096, 1266, 1096, 1299, 958, 1299], "text": "potentially", "confidence": "Low"}, {"boundingBox": [1103, 1266, 1167, 1266, 1167, 1299, 1103, 1299], "text": "long"}, {"boundingBox": [1173, 1266, 1230, 1265, 1230, 1299, 1173, 1299], "text": "term"}, {"boundingBox": [1246, 1265, 1396, 1264, 1395, 1298, 1246, 1299], "text": "tumorigenic", "confidence": "Low"}]}, {"boundingBox": [283, 1315, 1396, 1316, 1396, 1351, 282, 1350], "text": "effects of-thisese class of drugs. in humans. She also noted that in follow-up unspecified", "words": [{"boundingBox": [285, 1316, 368, 1317, 369, 1350, 286, 1349], "text": "effects", "confidence": "Low"}, {"boundingBox": [375, 1317, 498, 1318, 498, 1350, 376, 1350], "text": "of-thisese", "confidence": "Low"}, {"boundingBox": [504, 1318, 568, 1318, 568, 1351, 505, 1350], "text": "class"}, {"boundingBox": [574, 1318, 605, 1318, 606, 1351, 575, 1351], "text": "of"}, {"boundingBox": [612, 1318, 686, 1318, 687, 1351, 612, 1351], "text": "drugs.", "confidence": "Low"}, {"boundingBox": [693, 1318, 721, 1319, 722, 1351, 693, 1351], "text": "in"}, {"boundingBox": [728, 1319, 836, 1319, 836, 1351, 728, 1351], "text": "humans."}, {"boundingBox": [842, 1319, 888, 1319, 888, 1351, 842, 1351], "text": "She"}, {"boundingBox": [895, 1319, 947, 1319, 947, 1351, 895, 1351], "text": "also"}, {"boundingBox": [954, 1319, 1026, 1318, 1026, 1351, 954, 1351], "text": "noted"}, {"boundingBox": [1033, 1318, 1081, 1318, 1081, 1351, 1033, 1351], "text": "that"}, {"boundingBox": [1088, 1318, 1116, 1318, 1116, 1351, 1088, 1351], "text": "in"}, {"boundingBox": [1123, 1318, 1246, 1317, 1245, 1351, 1123, 1351], "text": "follow-up"}, {"boundingBox": [1252, 1317, 1395, 1316, 1394, 1350, 1252, 1351], "text": "unspecified"}]}, {"boundingBox": [278, 1373, 1284, 1374, 1283, 1403, 277, 1402], "text": "mechanistic studies, no evidence of irritation by crystalluria or calculi was noted.", "words": [{"boundingBox": [284, 1374, 435, 1374, 435, 1402, 283, 1400], "text": "mechanistic"}, {"boundingBox": [440, 1374, 534, 1374, 534, 1403, 440, 1402], "text": "studies,"}, {"boundingBox": [539, 1374, 573, 1374, 573, 1403, 539, 1403], "text": "no"}, {"boundingBox": [581, 1374, 692, 1374, 692, 1404, 581, 1403], "text": "evidence"}, {"boundingBox": [697, 1374, 726, 1374, 726, 1404, 697, 1404], "text": "of"}, {"boundingBox": [731, 1374, 838, 1374, 838, 1404, 731, 1404], "text": "irritation"}, {"boundingBox": [845, 1374, 879, 1374, 879, 1404, 845, 1404], "text": "by"}, {"boundingBox": [884, 1374, 1026, 1374, 1027, 1403, 884, 1404], "text": "crystalluria"}, {"boundingBox": [1031, 1374, 1060, 1374, 1060, 1403, 1032, 1403], "text": "or"}, {"boundingBox": [1065, 1374, 1149, 1374, 1150, 1402, 1065, 1403], "text": "calculi"}, {"boundingBox": [1154, 1374, 1204, 1374, 1205, 1401, 1155, 1402], "text": "was"}, {"boundingBox": [1210, 1374, 1282, 1374, 1282, 1400, 1210, 1401], "text": "noted."}]}, {"boundingBox": [284, 1473, 1402, 1474, 1401, 1509, 283, 1508], "text": "Dr. El-Hage then described a tumor promoter-model study that was conducted by another", "words": [{"boundingBox": [284, 1475, 325, 1475, 325, 1507, 285, 1507], "text": "Dr."}, {"boundingBox": [331, 1475, 436, 1476, 436, 1508, 332, 1507], "text": "El-Hage"}, {"boundingBox": [442, 1476, 500, 1476, 500, 1508, 443, 1508], "text": "then"}, {"boundingBox": [506, 1476, 624, 1477, 624, 1508, 507, 1508], "text": "described"}, {"boundingBox": [630, 1477, 645, 1477, 645, 1509, 630, 1508], "text": "a"}, {"boundingBox": [651, 1477, 728, 1477, 728, 1509, 652, 1509], "text": "tumor"}, {"boundingBox": [735, 1477, 937, 1477, 937, 1509, 735, 1509], "text": "promoter-model"}, {"boundingBox": [944, 1477, 1010, 1477, 1010, 1509, 944, 1509], "text": "study"}, {"boundingBox": [1016, 1477, 1068, 1477, 1067, 1509, 1016, 1509], "text": "that"}, {"boundingBox": [1074, 1477, 1123, 1476, 1123, 1509, 1074, 1509], "text": "was"}, {"boundingBox": [1130, 1476, 1255, 1475, 1255, 1509, 1129, 1509], "text": "conducted"}, {"boundingBox": [1262, 1475, 1296, 1475, 1296, 1509, 1262, 1509], "text": "by"}, {"boundingBox": [1302, 1475, 1401, 1474, 1400, 1509, 1302, 1509], "text": "another"}]}, {"boundingBox": [284, 1528, 1399, 1525, 1400, 1560, 285, 1563], "text": "sponsorcompany in which pioglitazone was administered. The study was designed as", "words": [{"boundingBox": [285, 1531, 496, 1530, 496, 1561, 285, 1562], "text": "sponsorcompany", "confidence": "Low"}, {"boundingBox": [504, 1530, 532, 1529, 532, 1561, 504, 1561], "text": "in"}, {"boundingBox": [542, 1529, 623, 1529, 622, 1561, 541, 1561], "text": "which"}, {"boundingBox": [629, 1529, 788, 1528, 788, 1561, 628, 1561], "text": "pioglitazone"}, {"boundingBox": [794, 1528, 850, 1527, 849, 1561, 794, 1561], "text": "was"}, {"boundingBox": [856, 1527, 1035, 1527, 1034, 1561, 855, 1561], "text": "administered."}, {"boundingBox": [1051, 1527, 1102, 1527, 1101, 1561, 1050, 1561], "text": "The"}, {"boundingBox": [1108, 1527, 1179, 1526, 1178, 1562, 1107, 1561], "text": "study"}, {"boundingBox": [1187, 1526, 1244, 1526, 1243, 1562, 1186, 1562], "text": "was"}, {"boundingBox": [1252, 1526, 1365, 1526, 1363, 1562, 1251, 1562], "text": "designed"}, {"boundingBox": [1371, 1526, 1400, 1526, 1399, 1562, 1369, 1562], "text": "as"}]}, {"boundingBox": [282, 1578, 393, 1581, 392, 1612, 281, 1609], "text": "follows:", "words": [{"boundingBox": [284, 1579, 393, 1581, 391, 1613, 284, 1609], "text": "follows:"}]}, {"boundingBox": [327, 1633, 1245, 1634, 1244, 1667, 326, 1666], "text": "BBN was given to male Fisher rats in their drinking water for four weeks.", "words": [{"boundingBox": [329, 1636, 388, 1636, 389, 1665, 330, 1664], "text": "BBN"}, {"boundingBox": [401, 1636, 451, 1635, 452, 1665, 402, 1665], "text": "was"}, {"boundingBox": [457, 1635, 527, 1635, 528, 1666, 458, 1665], "text": "given"}, {"boundingBox": [532, 1635, 558, 1635, 559, 1666, 533, 1666], "text": "to"}, {"boundingBox": [564, 1635, 627, 1635, 627, 1666, 565, 1666], "text": "male"}, {"boundingBox": [632, 1635, 712, 1634, 712, 1667, 633, 1667], "text": "Fisher"}, {"boundingBox": [717, 1634, 764, 1634, 764, 1667, 718, 1667], "text": "rats"}, {"boundingBox": [769, 1634, 795, 1634, 795, 1667, 770, 1667], "text": "in"}, {"boundingBox": [801, 1634, 862, 1634, 862, 1667, 801, 1667], "text": "their"}, {"boundingBox": [867, 1634, 974, 1634, 974, 1667, 867, 1667], "text": "drinking"}, {"boundingBox": [980, 1634, 1050, 1634, 1050, 1667, 980, 1667], "text": "water"}, {"boundingBox": [1056, 1634, 1095, 1634, 1094, 1667, 1056, 1667], "text": "for"}, {"boundingBox": [1100, 1634, 1154, 1634, 1153, 1667, 1100, 1667], "text": "four"}, {"boundingBox": [1159, 1634, 1245, 1634, 1244, 1666, 1159, 1667], "text": "weeks."}]}, {"boundingBox": [326, 1690, 692, 1689, 693, 1720, 327, 1721], "text": "Four groups were designated:", "words": [{"boundingBox": [331, 1691, 393, 1691, 391, 1721, 329, 1721], "text": "Four"}, {"boundingBox": [398, 1691, 484, 1691, 483, 1722, 397, 1721], "text": "groups"}, {"boundingBox": [490, 1691, 554, 1690, 553, 1722, 489, 1722], "text": "were"}, {"boundingBox": [560, 1690, 692, 1690, 691, 1722, 559, 1722], "text": "designated:"}]}, {"boundingBox": [340, 1742, 849, 1739, 850, 1775, 341, 1778], "text": "Pioglitazone 40 mg/kg/day after BBN", "words": [{"boundingBox": [376, 1742, 531, 1743, 531, 1778, 374, 1777], "text": "Pioglitazone"}, {"boundingBox": [538, 1743, 569, 1743, 569, 1778, 538, 1778], "text": "40"}, {"boundingBox": [576, 1743, 709, 1742, 710, 1776, 576, 1778], "text": "mg/kg/day"}, {"boundingBox": [716, 1742, 774, 1742, 775, 1775, 717, 1776], "text": "after"}, {"boundingBox": [780, 1742, 843, 1741, 844, 1773, 782, 1775], "text": "BBN"}]}, {"boundingBox": [96, 2094, 547, 2095, 546, 2127, 95, 2125], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [102, 2095, 230, 2097, 230, 2125, 103, 2125], "text": "Confidential"}, {"boundingBox": [236, 2097, 246, 2097, 246, 2125, 236, 2125], "text": "-"}, {"boundingBox": [252, 2097, 334, 2097, 334, 2125, 253, 2125], "text": "Subject"}, {"boundingBox": [340, 2097, 360, 2097, 360, 2125, 340, 2125], "text": "to"}, {"boundingBox": [366, 2097, 476, 2097, 475, 2127, 366, 2125], "text": "Protective"}, {"boundingBox": [482, 2097, 547, 2096, 546, 2128, 482, 2127], "text": "Order"}]}, {"boundingBox": [1291, 2092, 1572, 2093, 1571, 2123, 1290, 2122], "text": "TAK-BAROND-00301714", "words": [{"boundingBox": [1296, 2094, 1572, 2093, 1571, 2124, 1297, 2121], "text": "TAK-BAROND-00301714"}]}, {"boundingBox": [1248, 2124, 1576, 2122, 1576, 2150, 1249, 2153], "text": "Produced in MDL on 09/08/12", "words": [{"boundingBox": [1250, 2127, 1355, 2127, 1355, 2152, 1251, 2152], "text": "Produced"}, {"boundingBox": [1360, 2127, 1381, 2127, 1381, 2151, 1360, 2152], "text": "in"}, {"boundingBox": [1386, 2127, 1440, 2126, 1440, 2151, 1386, 2151], "text": "MDL"}, {"boundingBox": [1445, 2126, 1474, 2125, 1473, 2151, 1445, 2151], "text": "on"}, {"boundingBox": [1479, 2125, 1575, 2122, 1574, 2151, 1478, 2151], "text": "09/08/12"}]}, {"boundingBox": [386, 2193, 1310, 2191, 1311, 2231, 387, 2232], "text": "Source: https://www.indup6319-oooonts.ucsf.edu/docs/rtjf0226", "words": [{"boundingBox": [391, 2197, 506, 2197, 506, 2230, 391, 2228], "text": "Source:"}, {"boundingBox": [512, 2197, 1310, 2192, 1311, 2228, 512, 2230], "text": "https://www.indup6319-oooonts.ucsf.edu/docs/rtjf0226", "confidence": "Low"}]}]}]}